Impact of Daily Stair Climbing on Cardiopulmonary Rehabilitation in Heart Patients (RIME)

August 11, 2026 updated by: Centre Hospitalier Arras

Impact of Daily Stair Climbing on Cardiopulmonary Rehabilitation in Heart Patients : Single-center Comparative Study in Eole Unit of Arras Hospital Center

The goal of this interventional study is to improve exercise capacity of patients following a standard rehabilitation program in Arras Hospital with stair climbing .

Patients will be randomized in to 2 groups : intervention or control.

  • Control group will follow standard program.
  • Intervention group will follow standard program and stair climbing (2 floors, twice a day until the exit).

Patients will complete questionnaires and tests before starting study and again at the end (approximately 10 days).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years
  • Patients requiring cardiac rehabilitation admitted to the Eole unit
  • Patients ability to walk at least 200 meters without technical assistance

Exclusion Criteria:

  • Patient walking with an assistive device
  • Patient with a contraindication to climbing stairs
  • Pre-operative patient
  • Patient with a pacemaker
  • Patient with an implanted defibrillator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: standard program of rehabilitation + stair climb
Patients will follow standard program + 2 times a day, until exit service (excluding weekends), they will climb two floors of stairs (morning and afternoon, supervised by a therapist)
Other: stair climb
2 times a day, until exit service (excluding weekends), they will climb two floors of stairs (morning and afternoon, supervised by a therapist)
No Intervention: Standard program of rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of number of repetitions on chair stand test
Time Frame: at 10 days or at time of study exit if the patient leaves earlier
Evolution of number of repetitions in 1 minute on chair stand test between entry and exit of study
at 10 days or at time of study exit if the patient leaves earlier

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of dyspnea
Time Frame: at 10 days or at time of study exit if the patient leaves earlier

Evolution of dyspnea (with Modified Medical Research Council (mMRC) scale) between entry and exit of study.

The scale is from 0 to 4. The higher the stage, the more severe the dyspnea.
at 10 days or at time of study exit if the patient leaves earlier
Evolution of distance covered on 6-minute walk test
Time Frame: at 10 days or at time of study exit if the patient leaves earlier
Evolution of distance covered on 6-minute walk test between entry and exit of study.
at 10 days or at time of study exit if the patient leaves earlier
Evolution of quality life score
Time Frame: at 10 days or at time of study exit if the patient leaves earlier
Evolution of quality life score with the World Health Organization Quality of Life Bref (WHOQOL Bref) questionnaire between entry and exit study. Measures overall quality of life in four domains: physical, psychological, social relationships, and environment.
at 10 days or at time of study exit if the patient leaves earlier
Evolution of muscle mass of lower limb
Time Frame: at 10 days or at time of study exit if the patient leaves earlier
Evolution of muscle mass in lower limb muscle mass measured by bioelectrical impedance between entry and exit of study
at 10 days or at time of study exit if the patient leaves earlier
Evolution of heart rate post exercise
Time Frame: at 10 days or at time of study exit if the patient leaves earlier
Evolution of heart rate post exercise between entry and exit study
at 10 days or at time of study exit if the patient leaves earlier

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Arras

Investigators

  • Principal Investigator: Marion FRERE, Arras hospital Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2026

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Study Registration Dates

First Submitted

June 4, 2026

First Submitted That Met QC Criteria

July 3, 2026

First Posted (Actual)

July 9, 2026

Study Record Updates

Last Update Posted (Actual)

August 13, 2026

Last Update Submitted That Met QC Criteria

August 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe